Pharma Stalls U.S., Korean Free Trade Talks

Law360, New York (November 9, 2006, 12:00 AM EST) -- U.S. and Korean negotiators are struggling to bridge their differences in talks to amend South Korea’s regulatory regime for patented drugs, according to sources close to the negotiations.

The talks, part of negotiations between U.S. and South Korea for a Free Trade Agreement, have stalled because both parties think their differences are too great to be bridged without major concessions, said a lawyer in Seoul who has been advising the government on the talks.

But officials have decided to meet again in Seoul late this week...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.